Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Insulet Corp.

Insulet Corp. (PODD) Stock Overview

Explore Insulet Corp.’s financial performance, market position, analyst ratings, and future outlook.

PODD●NASDAQ
HealthcareMedical - Devices
$146.44
$1.38(0.95%)
U.S. Market opens in 3h 5m

Insulet Corp. (PODD)

Meyka AI Score

Z

Key Financials

Market Cap10.1B
P/E Ratio27.15
EPS (TTM)$5.87
ROE0.27%
Fundamental Analysis

AI Price Forecasts

1 Month$179.22
3 Months$146.30
1 Year Target$249.90

PODD Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Insulet Corp. (NASDAQ: PODD) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Insulet Corp.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of PODD on the NASDAQ shows an RSI of 42.84, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $249.90 for the NASDAQ listing.

Key metrics behind Insulet Corp.'s NASDAQ-traded stock include a P/E ratio of 27.15 and a market capitalization of 10.1B. Combined with our AI analysis, these give both institutional and retail investors a clear view of PODD on the NASDAQ.

Price Performance (NASDAQ: PODD)

1-Day Change
0.95%
5-Day Change
6.12%
1-Month Change
-9.64%
3-Month Change
-1.61%
6-Month Change
-39.67%
Year-to-Date (YTD) Change
-48.48%
1-Year Change
-52.56%
3-Year Change
-34.59%
5-Year Change
-49.08%
All-Time (Max) Change
817.54%

Contact Information

https://www.insulet.com
978 600 7000
100 Nagog Park, Acton, MA, 01720

Company Facts

54,000 Employees
IPO DateMay 15, 2007
CountryUS
Actively Trading

Frequently Asked Questions